Rosecliff Acquisition I (MDAI) Gross Profit Margin starting from the second quarter 2026 to second quarter 2024, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Rosecliff Acquisition Corp I  (NASDAQ: MDAI)


Rosecliff Acquisition I's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MDAI Gross Profit Margin (Jun 30 2026)
Q2 		(Dec 31 2025)
Q4 		(Sep 30 2025)
Q3 		(Jun 30 2025)
Q2 		(Dec 31 2024)
Q4
Y / Y Revenue Change -53.66 %
Seq. Revenue Change -13.75 %
Revenue In Millions $3.52
Gross Profit Margin 31.58 %
Gross Profit Margin Total Ranking # 1681
Gross Profit In Millions $1.11
Y / Y Gross Profit Change -66.76 %
Seq. Gross Profit Change -


Commenting Second Quarter 2026 Gross Profit Margin
Rosecliff Acquisition Corp I achieved Gross Profit of $1 millions compare to Gross Loss of $0.00 millions booked in the previous quarter. Despite the sequential Revenue deterioration in Q2 of -13.75 % Rosecliff Acquisition Corp I managed to reduce Cost of Sales and turn into profitability by achieving a Gross Profit of 1 compare to Gross Loss of $0.00 millions realized in the previous quarter. Company accomplished Gross Profit Margin of 31.58 %, below company average.


Observing second quarter 2026 results within Medical Equipment & Supplies industry 118 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from to 1681.
Learn about Gross Margin
MDAI's Gross Profit Margin second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 119
Healthcare Sector # 306
Overall # 1669

Gross Profit Margin Statistics
High Average Low
613.96 % 92.64 % 31.58 %
(Sep 30 2022)   (Jun 30 2026)


MDAI Gross Income Trends • More of MDAI's Profitabilty Ratios • MDAI Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
MDAI's Cumulative Gross Profit Margin
Medical Equipment & Supplies Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
MDAI's Gross Profit Margin Profitability versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for MDAI's Competitors
Gross Profit Margin Profit Margin for Rosecliff Acquisition I's Suppliers
Gross Profit Margin Profit Margin for MDAI's Customers

You may also want to know
MDAI's Annual Growth Rates MDAI's Profitability Ratios MDAI's Asset Turnover Ratio MDAI's Dividend Growth
MDAI's Roe MDAI's Valuation Ratios MDAI's Financial Strength Ratios MDAI's Gross Profit Growth
MDAI's Roa MDAI's Inventory Turnover Ratio MDAI's Growth Rates MDAI's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Gross Profit MarginJun 30 2026 MRQ Gross ProfitJun 30 2026 MRQ Revenue
Trisalus Life Sciences Inc   86.78 %$ 9.899  Millions$ 11.407  Millions
Electrocore Inc   86.53 %$ 8.177  Millions$ 9.450  Millions
Sharps Technology Inc   86.06 %$ 1.755  Millions$ 2.039  Millions
Neuraxis Inc   85.87 %$ 1.656  Millions$ 1.929  Millions
Inspire Medical Systems inc   85.48 %$ 171.459  Millions$ 200.581  Millions
Mobia Medical Inc   83.21 %$ 11.238  Millions$ 13.505  Millions
Heartflow Inc   83.00 %$ 53.190  Millions$ 64.082  Millions
Neuropace Inc   82.83 %$ 18.906  Millions$ 22.826  Millions
Vycor Medical Inc   82.35 %$ 0.344  Millions$ 0.418  Millions
Avita Medical Inc   81.87 %$ 17.767  Millions$ 21.702  Millions
Glaukos Corp  81.67 %$ 151.594  Millions$ 185.610  Millions
Si bone inc   79.54 %$ 44.548  Millions$ 56.010  Millions
Vaso Corporation  79.46 %$ 8.889  Millions$ 11.187  Millions
Electromed Inc   78.71 %$ 15.284  Millions$ 19.417  Millions
Treace Medical Concepts Inc   78.47 %$ 35.607  Millions$ 45.376  Millions
Profound Medical Corp   78.41 %$ 1.947  Millions$ 2.483  Millions
Pulmonx Corporation  77.97 %$ 17.742  Millions$ 22.756  Millions
Novocure Limited  77.61 %$ 142.478  Millions$ 183.584  Millions
Edwards Lifesciences Corporation  77.46 %$ 1,348.600  Millions$ 1,741.000  Millions
Atricure Inc   77.23 %$ 118.629  Millions$ 153.604  Millions
Anteris Technologies Global Corp   76.91 %$ 0.776  Millions$ 1.009  Millions
Carlsmed Inc   76.78 %$ 14.542  Millions$ 18.940  Millions
Rxsight Inc   76.72 %$ 25.886  Millions$ 33.741  Millions
Tactile Systems Technology Inc   76.25 %$ 65.349  Millions$ 85.698  Millions
Sanuwave Health Inc   76.23 %$ 7.424  Millions$ 9.739  Millions
Nuwellis Inc   76.08 %$ 1.498  Millions$ 1.969  Millions
Staar Surgical Co  74.55 %$ 69.727  Millions$ 93.535  Millions
Orthopediatrics Corp  74.27 %$ 52.366  Millions$ 70.508  Millions
Iradimed Corporation  74.07 %$ 15.160  Millions$ 20.466  Millions
Cytosorbents Corporation  73.18 %$ 7.049  Millions$ 9.633  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.